Select Page

PROMACTA (eltrombopag) for oral suspension Initial U.S. Approval: 2008

PROMACTA (eltrombopag) for oral suspension Initial U.S. Approval: 2008

PROMACTA is a Anti Cancer medicine. PROMACTA is used to treat blood disorder called chronic immune (idiopathic) thrombocytopenia purpura (ITP) aplastic anemia.
INDICATIONS AND USAGE
PROMACTA is a thrombopoietin receptor agonist indicated for the treatment of:
• thrombocytopenia in adult and pediatric patients 1 year and older with chronic immune (idiopathic) thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy.
• thrombocytopenia in patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy.
• patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy.
DOSAGE FORMS & STRENGTHS
• Tablets: 12.5 mg, 25 mg, 50 mg, 75 mg, and 100 mg
• For oral suspension: 25 mg
Manufactured By: GlaxoSmithKline
Prescribing Information URL: Click Here

Procedure to buy PROMACTA (eltrombopag) for oral suspension?
To buy PROMACTA (eltrombopag) for oral suspension, patients can simply fill the order form or can send mail at info@bioniquehealthcare.com. or can also send Whatsapp message at +91 96677 50889. You will get reply within few hours with pricing and procedure details. Note:- the order will be confirmed only after the receipt of valid prescription of doctor.

Category:

Eltrombopag is a medication that has been developed for certain conditions that lead to thrombocytopenia (abnormally low platelet counts). It is a small molecule agonist of the c-mpl (TpoR) receptor, which is the physiological target of the hormone thrombopoietin. Eltrombopag was discovered as a result of research collaboration between GlaxoSmithKline and Ligand Pharmaceuticals. Designated an orphan drug in the United States and European Union, it is being manufactured and marketed by Novartis under the trade name Promacta in the US and is marketed as Revolade in the EU. Novartis acquired the drug as a part of its asset swap deal with GlaxoSmithKline.

Documentation

  1. Doctor’s Prescription – We would require prescription from registered medical practitioner stating product name, dosage, duration of treatment and diagnosis.
  2. Patient’s Medical history – We would require all test reports and medical reports of the patient for last 3 months.
  3. Patient’s Identity card – We will require scan copy of patient’s identity card and proof of residence to initiate documentation process. you can use copy of passport, driving license, employee ID card or any photo id document as your identity card.

For Overseas Patient

Can I get anti-cancer medicines even if I am not based in India?

Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country. The Bionique Healthcare can help patients in accessing/importing Ant-cancer medicines, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.

Send your query to find the best price of –

PROMACTA (eltrombopag) for oral suspension in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.
PROMACTA (eltrombopag) for oral suspension in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.
PROMACTA (eltrombopag) for oral suspension in North America – Mexico.
PROMACTA (eltrombopag) for oral suspension in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.
PROMACTA (eltrombopag) for oral suspension in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.
PROMACTA (eltrombopag) for oral suspension in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.
PROMACTA (eltrombopag) for oral suspension in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.
PROMACTA (eltrombopag) for oral suspension in Australia and New Zealand.

For Indian Patient

Ani-Cancer PROMACTA (eltrombopag) for oral suspension are prescription drug. 

We facilitate by-

  • Helping in documentation to import the medicine for personal use.
  • Finding Genuine and reliable source in USA, Europe and Japan.
  • Ensuring 100% transparency.

PROMACTA (eltrombopag) for oral suspension can be shipped to Ahmedabad, Bangalore, Chennai, Cochin, Hyderabad, Delhi, Haryana, Jaipur, Jammu and Kashmir, Himachal Pradesh, Kolkata, Lucknow, Mumbai, Pune, Punjab and other cities in India. Bionique Healthcare does not manufacture, supply, re-sell or retail any drugs or medicines. 

Reviews

There are no reviews yet.

Be the first to review “PROMACTA (eltrombopag) for oral suspension Initial U.S. Approval: 2008”

Your email address will not be published.

Anti-Cancer Medicine Supplier.

Bionique Healthcare is a consulting pharmaceutical company which assist Patients in accessing medicines in India. Bionique Healthcare facilitates such access only against valid prescriptions in conformity with all local laws and regulations.

Patients/ Clinicians / Researchers can contact Bionique at +91 9667750889 or write to at – info@bioniquehealthcare.com.

Product Disclaimer

Bionique Healthcare does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturer or licensee. 

Bionique Healthcare does not lay any claim on them.